| Emmanuel Daon, MD | |
|
3901 Rainbow Blvd, Mailstop 4035, Kansas City, KS 66160-0001 | |
| (913) 588-9797 | |
| (913) 588-9786 |
| Full Name | Emmanuel Daon |
|---|---|
| Gender | Male |
| Speciality | Cardiac Surgery |
| Experience | 31 Years |
| Location | 3901 Rainbow Blvd, Kansas City, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770534018 | NPI | - | NPPES |
| 100391360A | Medicaid | KS | |
| 207974312 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 103241 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Kansas Hospital | Kansas city, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Kansas Hospital Authority | 9436054798 | 250 |
| University Of Kansas Hospital Authority | 9436054798 | 250 |
News Archive
Nothing less than the development of a passive vaccine against Covid-19 has been undertaken by a team of scientists from Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinkum Erlangen and their partners from the Fraunhofer Institute for Cell Therapy and Immunology in Leipzig and the German Primate Centre in Göttingen.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Eprosartan Mesylate Tablets, 400 mg (base) and 600 mg (base).
An analysis of data from previously published studies indicates that intensive-dose statin therapy is associated with an increased risk of new-onset diabetes compared with moderate-dose therapy, according to a study in the June 22/29 issue of JAMA.
CMS has issued a new rule requiring hospice providers participating in Medicare to implement a quality assessment and improvement system, the Washington Post reports.
› Verified 9 days ago
| Entity Name | University Of Kansas Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528019502 PECOS PAC ID: 9436054798 Enrollment ID: O20110607000604 |
News Archive
Nothing less than the development of a passive vaccine against Covid-19 has been undertaken by a team of scientists from Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinkum Erlangen and their partners from the Fraunhofer Institute for Cell Therapy and Immunology in Leipzig and the German Primate Centre in Göttingen.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Eprosartan Mesylate Tablets, 400 mg (base) and 600 mg (base).
An analysis of data from previously published studies indicates that intensive-dose statin therapy is associated with an increased risk of new-onset diabetes compared with moderate-dose therapy, according to a study in the June 22/29 issue of JAMA.
CMS has issued a new rule requiring hospice providers participating in Medicare to implement a quality assessment and improvement system, the Washington Post reports.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emmanuel Daon, MD 3901 Rainbow Blvd, Mailstop 4035, Kansas City, KS 66160-0001 Ph: (913) 588-9797 | Emmanuel Daon, MD 3901 Rainbow Blvd, Mailstop 4035, Kansas City, KS 66160-0001 Ph: (913) 588-9797 |
News Archive
Nothing less than the development of a passive vaccine against Covid-19 has been undertaken by a team of scientists from Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinkum Erlangen and their partners from the Fraunhofer Institute for Cell Therapy and Immunology in Leipzig and the German Primate Centre in Göttingen.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Eprosartan Mesylate Tablets, 400 mg (base) and 600 mg (base).
An analysis of data from previously published studies indicates that intensive-dose statin therapy is associated with an increased risk of new-onset diabetes compared with moderate-dose therapy, according to a study in the June 22/29 issue of JAMA.
CMS has issued a new rule requiring hospice providers participating in Medicare to implement a quality assessment and improvement system, the Washington Post reports.
› Verified 9 days ago
Jessica K Heimes, DO Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Ms 2005, Kansas City, KS 66103 Phone: 913-588-6124 Fax: 913-588-7540 | |
James Tyler Zorn, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 4000 Cambridge St Ste G600, Kansas City, KS 66160 Phone: 813-588-9600 | |
Dr. Matthew Robert Danter, BSC, MD, FRCSC Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 4000 Cambridge St, Kansas City, KS 66160 Phone: 913-588-4377 | |
Todd Christopher Crawford, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 4000 Cambridge St Ste G600, Kansas City, KS 66160 Phone: 913-588-7743 | |
Dr. Keith Blaine Allen, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 4320 Wornall Rd, Ste 50 11, Kansas City, KS 64111 Phone: 816-931-3312 Fax: 816-531-9862 | |
Chad Burton Cash, DO Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-5235 | |
Dr. Michael F Meurer, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 8919 Parallel Pkwy, Suite 455, Kansas City, KS 66112 Phone: 913-825-0500 Fax: 913-825-0505 |